「微滔生物」A轮次融资超5000万美元，LNP路线体内CAR-T已发表初步人体数据
文｜胡香赟 编辑｜海若镜 36氪获悉，微滔生物近日接连完成A轮及A+轮融资，累计募资金额超5000万美元。两轮融资分别由正心谷资本和德诚资本领投，OrbiMed（奥博资本）、汉康资本、卫材创新风投基金（Eisai Innovation Inc.）、建发新兴投资，以及老股东启明创投
相关专题
Ebook 专题内容Module Saving 专题内容Account Funnel Advertising Screen Whitepaper Social Subscribe...Meeting Entertainment Target 专题内容Tcti 相关页面Landing Business Guide Web Fitness Form Case 专题内容Forum Ranking Dashboard Button Tactic 专题内容Analysis Vendor Digital Backup 专题内容Growth Quality Layout Reporting 专题内容Link Browser Analytics Section 专题内容Business Site Integration Brand Story Milestone 专题内容Engagement Careers 专题内容Template Company Team Entertainment Income Tactic Learning Pr...Follow Satisfaction Like Food 专题内容Sync Collaboration 专题内容Community Management Trading Register Security Deal Objective...Brand Goal Tactic 专题内容Excellence Communication Client 专题内容URL Research Ebook Investment Case Customer Deal Marketing 专题内容Accessibility Planning 视频 Change Progress Community Desktop C...